We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
101
Ranger Investment Management
Texas
$3.06M +$2.72M +44,487 New
GIA
102
Gargoyle Investment Advisor
New Jersey
$2.92M +$2.6M +42,537 New
Two Sigma Advisers
103
Two Sigma Advisers
New York
$2.91M +$2.59M +42,385 New
Barclays
104
Barclays
United Kingdom
$2.9M +$2.58M +42,194 New
State of Wisconsin Investment Board
105
State of Wisconsin Investment Board
Wisconsin
$2.82M +$2.51M +41,090 New
BA
106
Boston Advisors
Massachusetts
$2.79M +$2.48M +40,590 New
CCM
107
Catapult Capital Management
New York
$2.75M +$2.44M +40,000 New
NFA
108
Nationwide Fund Advisors
Ohio
$2.72M +$2.42M +39,616 New
ProShare Advisors
109
ProShare Advisors
Maryland
$2.71M +$2.41M +39,455 New
N
110
Nuveen
North Carolina
$2.53M +$2.25M +36,846 New
MAA
111
Managed Account Advisors
New Jersey
$2.48M +$2.2M +36,068 New
CM
112
Castleark Management
Illinois
$2.45M +$2.18M +35,705 New
DekaBank Deutsche Girozentrale
113
DekaBank Deutsche Girozentrale
Germany
$2.38M +$2.12M +34,704 New
AIC
114
Aurora Investment Counsel
Georgia
$1.95M +$1.65M +26,992 New
DIA
115
Dana Investment Advisors
Wisconsin
$1.92M +$1.7M +27,882 New
ACP
116
Aviance Capital Partners
Florida
$1.88M +$1.67M +27,350 New
VOYA Investment Management
117
VOYA Investment Management
Georgia
$1.88M +$1.67M +27,325 New
TD Asset Management
118
TD Asset Management
Ontario, Canada
$1.82M +$1.62M +26,500 New
NIP
119
Nicholas Investment Partners
California
$1.78M +$1.59M +25,967 New
HighTower Advisors
120
HighTower Advisors
Illinois
$1.76M +$1.48M +24,232 New
Asset Management One
121
Asset Management One
Japan
$1.71M +$1.52M +24,928 New
GCP
122
GSA Capital Partners
United Kingdom
$1.7M +$1.51M +24,781 New
PNC Financial Services Group
123
PNC Financial Services Group
Pennsylvania
$1.7M +$1.51M +24,732 New
MWNA
124
Marshall Wace North America
New York
$1.68M +$1.49M +24,450 New
Schroder Investment Management Group
125
Schroder Investment Management Group
United Kingdom
$1.66M +$1.48M +24,200 New
3 4
5
6 7

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.